Amundi
NVAX icon

Amundi’s Novavax NVAX Stock Holding History

Amundi’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,888
Closed -$69.8K – 2104
2022
Q4 		$69.8K Buy
5,888
+3,364
+133% +$59.4K ﹤0.01% 1653
2022
Q3 		$47K Hold
2,524
– – ﹤0.01% 1681
2022
Q2 		$130K Sell
2,524
-29,250
-92% -$1.52M ﹤0.01% 1414
2022
Q1 		$1.89M Sell
31,774
-37
-0.1% -$3.3K ﹤0.01% 1126
2021
Q4 		$3.57M Sell
31,811
-1,616
-5% -$278K ﹤0.01% 1081
2021
Q3 		$6.93M Buy
33,427
+6,221
+23% +$1.37M ﹤0.01% 934
2021
Q2 		$5.78M Buy
+27,206
New +$4.98M ﹤0.01% 974

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi's NVAX Position: Q1 2023 in Review

Amundi sold out of Novavax (NVAX) in Q1 2023, closing a stake of 5,888 shares — an estimated $69.8K sold.

Amundi first reported a position in NVAX in Q2 2021 and held it in 7 quarters. The position peaked at $6.93M in Q3 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Amundi reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Amundi sold 5,888 Novavax shares in Q1 2023, an estimated $69.8K.
  • Amundi first reported a position in Novavax in Q2 2021 and held it in 7 quarters.
  • Amundi's Novavax position peaked at $6.93M in Q3 2021.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.